Prevention of Recurrent High-Grade Anal Neoplasia With Quadrivalent Human Papillomavirus Vaccination of Men Who Have Sex With Men: A Nonconcurrent Cohort Study

Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males

(2011) Anna R. Giuliano et al.   NEW ENGLAND JOURNAL OF MEDICINE

Current understanding of the mechanism of HPV infection

(2010) John T. Schiller et al.   GYNECOLOGIC ONCOLOGY

Prevalence of and Risk Factors for Human Papillomavirus (HPV) Infection Among HIV-Seronegative Men Who Have Sex With Men

(2010) S. Goldstone et al.   JOURNAL OF INFECTIOUS DISEASES

Age-Specific Prevalence of and Risk Factors for Anal Human Papillomavirus (HPV) among Men Who Have Sex with Women and Men Who Have Sex with Men: The HPV in Men (HIM) Study

(2010) Alan G. Nyitray et al.   JOURNAL OF INFECTIOUS DISEASES

Should I or Shouldn’t I: Decision making, knowledge and behavioral effects of quadrivalent HPV vaccination in men who have sex with men

(2010) Emily A. Thomas et al.   VACCINE

Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24–45 years: a randomised, double-blind trial

(2009) Nubia Muñoz et al.   LANCET

Longer term efficacy of a prophylactic monovalent human papillomavirus type 16 vaccine

(2009) Ali Rowhani-Rahbar et al.   VACCINE

Imiquimod Leads to a Decrease of Human Papillomavirus DNA and to a Sustained Clearance of Anal Intraepithelial Neoplasia in HIV-Infected Men

(2008) Alexander Kreuter et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY